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facilitators to the routine adoption of
methodology research in clinical trials
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Abstract
Background: Randomised controlled trials are the cornerstone of evidence-based health care, yet many trials
struggle with recruitment and retention. All too often the methodologies employed to address these problems are
not evidence-based, as rigorous methodological research on these issues is rare. The current research sought to
identify barriers to the routine implementation of methodology research around recruitment and retention.
Methods: All registered UK clinical trials unit directors were sent a short questionnaire and invited to interview.
Representatives of funding bodies and other stakeholders were also approached. Interviews were recorded and the
content analysed.
Results: Data were grouped into four themes: acceptance of the need for methodological research; trial funding
and development; trial processes; and organisational factors. The need to improve the evidence base for trials
methodology is well established, but numerous barriers to implementation were perceived.
Conclusions: The knowledge and expertise required to routinely implement methodology research exists within
the current research structures, and there are clear opportunities to develop the evidence base. However, for this to
be achieved there is also a need for clear strategic coordination within the sector and promotion of the necessary
resources.
Keywords: RCTs, SWATS, Methodology research
Background
Randomised controlled trials are fundamental to
evidence-based practice. Increasing numbers of studies
are being conducted worldwide, but recruitment and re-
tention remain significant challenges. This highlights the
importance of methodological work to improve trial de-
livery and quality.
One way of improving trials is through ‘research on re-
search’: conducting methodology studies on the process
of collecting and analysing data. ‘Studies within a trial’
(SWATs) embed research within research, so as to
resolve uncertainties about the effects of different ways
of designing, conducting, analysing and interpreting
evaluations of health and social care [1]. They are poten-
tially efficient and effective ways of rapidly developing
the evidence base around the methodologies for trials,
taking advantage of existing trial activity to conduct add-
itional work. Such approaches are increasingly important
in the context of concerns about research waste [2].
Other terms common in the literature include ‘embed-
ded studies’, ‘nested’ studies or ‘methodological bolt-ons’.
The term SWAT is used here to denote all methodology
research embedded in trials.
The aspects of trial design and delivery tested in SWATs
vary, ranging from modest, no-cost or low-cost compari-
sons, such as modifying patient information sheets [3], to
more substantial endeavours (e.g. developing bespoke
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websites to support recruitment, training programmes for
recruitment staff ). Methods used in SWATs can include
simple before-and-after studies and non-randomised com-
parisons, but our particular interest is in the subset of
SWATs which themselves use a randomised design.
Despite the potential of SWATs to contribute to the
evidence base on trial conduct, they are rare. For ex-
ample, the Cochrane methodology review on recruit-
ment interventions identified only 45 embedded
methodology trials in real and hypothetical trials [4],
while the partner review on retention reported only 38
trials, many of which focused solely on boosting the re-
sponse to questionnaires [5]. Additionally, these reviews
reveal the piecemeal nature of the evidence, with a var-
iety of interventions tested in a range of trial contexts,
with few replications.
Some of the ‘downstream’ barriers and facilitators
amongst investigators to embed recruitment studies
have already been explored [6]. A recent programme of
work (Medical Research Council Systematic Techniques
for Assisting Recruitment to Trials (MRC START)) eval-
uated two recruitment interventions by implementing 10
SWATs in existing host trials [7]. This work demon-
strated the feasibility of the approach, but it also
highlighted a number of barriers that had an impact on
the decision to engage with SWATS. However, less is
known about the wider structural and organisational fac-
tors that influence the implementation of SWATs.
Trials are developed and delivered over a long time
scale, and our initial diagnosis of the barriers suggested
that many could be addressed through early engagement
in the trial development process, using ‘upstream’ inter-
ventions to overcome concerns on the part of investiga-
tors [6]. Important upstream influences are funders and
clinical trials units (CTUs, academic organisations set up
to specialise in the management and delivery of clinical
trials). We require a comprehensive assessment of the
organisational issues that might affect funders and CTUs
and how they might relate to the concerns of those run-
ning trials.
The current study aimed to:
1. Identify potential barriers to and facilitators of the
implementation of SWATs amongst trialists,
funders and CTUs
2. Develop policies and guidance to support greater
use of SWATs.
Methods
Sample and data collection
CTUs were established in the UK in 2007 as a way of
bringing together staff with the core skills needed to
deliver trials. CTUs focus on the design and delivery
of trials, running trials in their own right and offering
external teams a range of services from full trial man-
agement to support with design, data collection, data
management, statistical services or information tech-
nology (IT).
Directors of all 44 CTUs registered as of June 2015
were sent a short screening questionnaire asking
about SWAT activity and inviting them to an inter-
view. Nineteen responded, and 12 (63%) interviews
took place, involving 15 respondents (3 interviews
involved 2 people). Key representatives of the main
trial funders were also identified by the research
team. Senior trialists and trial managers were identi-
fied through interviews with CTU leads or through
their attendance at the UK Trial Manager Network
(UKTMN) conference in September 2015. An add-
itional 8 interviews were conducted with this second
group (4 with individual trial managers, and 4 with
funders, involving 5 respondents). In all, 24 people
were involved in the interviews.
Workshops and webinar
Two workshops were held during the course of the re-
search: one at the UKTMN annual conference and one
at the International Clinical Trials Methodology Confer-
ence (ICTMC), both in late 2015. A webinar, open to all
UKTMN members, was held in December 2015.
Data collection
We report the qualitative research in line with the Con-
solidated Criteria for Reporting Qualitative Research
(COREQ) guidance [8]. All potential interviewees were
sent a participant information sheet, consent form and
covering email, asking them to participate in an inter-
view. Interviews took place between July 2015 and Janu-
ary 2016. Interviews were predominantly conducted by
phone by JR (female health services researcher with a
PhD and experience with conducting interviews), using
a semi-structured interview guide and were mostly digit-
ally recorded and transcribed (a minority were recorded
by hand). Interviews ranged in length from 30 to
90 min, with the majority lasting around an hour (aver-
age = 58 min). Most of the interviewees had no previous
relationship with or knowledge of the researcher prior to
the study. Additional material was collected via work-
shops at two conferences with trial managers, academics
and clinicians with an interest in methodology, and via a
webinar hosted by the UKTMN. Notes were taken at the
workshops and webinar and used to inform interpret-
ation of results.
Data analysis
Interviews were transcribed and entered into NVivo.
Coding was done by one researcher (JR). We did not re-
turn transcripts to participants for comment, nor did we
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ask them to comment on the findings. As noted earlier,
our preliminary work suggested that implementation of
SWATs amongst trialists would be affected by the oper-
ation of two key organisations: funding bodies and
CTUs. Transcripts were thus coded using a framework
of relevance to understanding organisational function.
The McKinsey 7S model was originally developed as a
model of organisational change [9]. It is a useful frame-
work for understanding how organisations deal with
multiple priorities and pressures. McKinsey 7S identifies
seven interrelated factors or elements that influence an
organisation’s ability or readiness to implement a strat-
egy (strategy, structure, systems, shared values, staff,
style and skills). The model is relatively simple and suit-
able for use in varying contexts. It is used here as a
framework through which to consider the organisational
aspects of CTUs that can act as barriers or facilitators to
SWATs.
Results
Data were grouped into four broad themes:
1. Understanding and acceptance of the need for
SWATs
2. Wider context of trial development and funding
3. Specific stages of trial development, implementation
and delivery
4. Organisational aspects of CTUs (using the
McKinsey 7S model)
Understanding and acceptance of the need for SWATs
Recognition of the need for SWATs was well established
amongst CTU leads, senior trialists and trial managers
interviewed here. As one senior trialist commented:
… for at least 50 years people have struggled with the
idea of making trials as efficient as they can be…and
every time you looked at the literature, people were
still struggling … and they still are…clearly things are
not improving in the way we think they should.
However, this recognition was not seen to extend to
the wider trial community, where Chief Investigators
(CIs) or other trial management group members were
frequently cited as barriers to employing SWAT meth-
odology. The types of concerns encountered tended to
focus on resisting further complexity, increasing work-
load, a belief in a particular methodological approach
(lack of equipoise) or fear of reducing recruitment in
one arm:
I did raise it with one CI … around payment for follow
up data … they said ’we don’t want a randomised
payment or no payment because we believe it works’ …
they wanted to give it to everybody because they don’t
want to risk reducing the recruitment in one arm…
I did put in a section [on the application] saying we
are going to do an embedded trial, but all the other
applicants thought this was a distraction and wanted
me to take it out, which I did
Good relationships (normally between CTU and CI
and occasionally between trial manager and CI) and
shared values around methodology research were cited
numerous times as important facilitators:
If you’ve got a long standing relationship, that’s fine,
but if they are a new CI you might not want to raise it
necessarily.
Opinion was divided on the role of academic clinicians
in promoting or supporting embedded methodology re-
search and SWATs:
I think clinician CIs, because they are less experienced
can go along with whatever you say, whereas
academics, who maybe feel they could get the grant in
their own right, are more likely to want to do what
they want…
Another potential facilitator of SWATs was the extent to
which CTUs could make inclusion of a SWAT conditional
for accepting a trial or application, and the continued pro-
motion of this type of work through dissemination, net-
working and support.
Some interviewees questioned the need for or suitabil-
ity of SWATs. Exceptions included examples of im-
proved trial procedure that they did not feel needed to
be tested:
Within the CTU we’re always looking at how we can
improve our systems and processes of running trials,
we just don’t do it by, sort of, formally randomising to
do method A or method B … We know it’s working
because we know it happens quicker…
Some trial settings were seen as inappropriate for a
SWAT:
A lot of the time we’re recruiting patients the night before
they go in for major surgery … so it’s difficult to imagine
what we could embed methodologically given the sort of
patient pathway we work with most of the time.
Finally, there were mixed comments from funder rep-
resentatives, with one contending that SWATs are too
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narrow in focus: the approach misses key determinants
of successful trials. Issues are not how to recruit, but
management style and leadership:
My impression of the literature … is that it’s adopted a
rather too narrow study design paradigm … in terms
of fixed interventions and …randomised controlled
trials. I think there’s often modest differences between
individual interventions and the trials that are
successful are not because they’ve adopted a particular
approach … it’s because they’ve been just really well
organised
Other funder views aligned more with those of CTU
leads, acknowledging the need to improve the evidence
base on recruitment and retention strategies.
Wider trial development and funding context
Substantial differences existed in perceptions about
availability of funding for methodology work. For those
engaged in delivering research, difficulty in accessing
funds was the most significant barrier. None of the
current funding streams were seen as open to funding
stand-alone SWAT applications:
So we think it’s a good thing, and also one of our other
objectives is to do more methodological work and there
aren’t many funding streams for methodological work.
In fact I can’t really find any, so…
Views from representatives of funding agencies were
mixed, but on the whole reflected a more positive view,
citing examples where the opportunity for ‘methodo-
logical bolt-ons’ existed:
The [methodological bolt-ons] were put on there in the
sense that if people are funded to do a trial using some
new method … is there some additional research that
might be done to either evaluate or test the validity of
the approach that is being done? So, we haven’t any
more thoughts on that …
Some funders reported shifts in policy towards more
applied work:
It was decided to look at whether there should be
changes to the structure and membership of the
[Panel] to try and make sure we got more of an
applied bent … it was an attempt to increase [applied
methodology research] but of course we’re entirely
reliant on the applications that come to us
Outside these programmes, there was some indication
from funders that applications for SWATS as part of a
full trial funding application could be considered ‘in
scope’:
But, you know, something of modest scale that
represents an internal evaluation of recruitment
methods, in order to inform the conduct of the later
phase of the trial, seems entirely reasonable.
However, from the perspective of trialists, there was
not always clarity about access to funds:
I guess knowing that the funder actually wants to see
it and is prepared to pay for it and upfront explicitly
say, because otherwise you’ll just think, oh well they’ll
say, why have you put this extra thing in, it just makes
it more complicated and more expensive?
From a funder perspective that meant clearer commu-
nication about funding for SWATs:
Interviewer: There seems to be a perception that it’s
[SWATs] not something [funder] would fund …
Respondent: Yes … I think it’s an incorrect perception,
but a widely held perception
Several other contextual factors were identified by re-
searchers as barriers to the adoption of SWATs. Timing
pressures in the trial funding cycle were commonly
mentioned as the main factor working against the added
complexity of developing and introducing SWATS:
At the moment the way they’ve got the expression of
interest to the full in seven weeks, either over
Christmas, over summer or over Easter is just not
giving you the opportunity to start being creative
about method study.
However, several interviewees noted that efforts to
co-ordinate ideas and develop ‘off-the-shelf ’ interven-
tions could act as a facilitator in this setting.
A second barrier of considerable concern relates to
costs and competition. Many perceive current funding
strategy as placing great emphasis on cost saving, value
for money and efficiency. Ironically, in this context CIs
and CTUs tend to strip design back and are keen to en-
sure no extraneous costs in funding proposals, acting as
a barrier to SWATs. CTU leads in particular expressed
concerns about whether additional costs for SWATs
could have an impact on their competitiveness:
I think like with any trials unit we are always being
pushed back on our costs, and our costs, I would
argue, are actually very competitive. There’s always
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that pressure to do all that you want to do for less
because of the fear that it will get knocked back by the
funding board if it’s seen to be too expensive.
Specific stages of trial development, implementation and
delivery
There were many comments about the detailed process
of implementing a SWAT. A number of key stages of
trial development, implementation and delivery were
noted, but a considerable proportion related to activ-
ities that could be considered as earlier stages. Moving
from support for the principle to idea generation for a
specific SWAT was one area of difficulty. Concerns re-
lated partly to timing (as noted above) but also the
broader question of what constitutes a worthwhile
intervention to test:
Yes. And I think the other element to all of that is the
timing of it all. We’ve had a lot of discussions about
how much of a time window we have between people
approaching us and then a funding deadline, so it’s
then on top of all of what you have to do anyway,
building in this. It’s whether you’ve got something
ready to go and you think, oh, this trial would be
perfect, or whether it’s developing something from
scratch.
There was particular support for some form of
agenda-setting for research priorities and co-ordinating
efforts around specific questions to have maximum im-
pact, possibly forming collaborations with small groups
of CTUs:
Yes, one of the key things I always talk about with this
Trial Forge idea which is sort of distilling down now to
essentially one line, three words, it’s ‘coordination and
collaboration’. The first bit is that coordination, it’s
what should we do? Again that removes a barrier if
you can say, well, here are some things to do, and in
fact if we take the IQuaD example, not only: here are
some things, but here is the thing to do. It removes a
barrier, you just make a decision, do I want to take
part or not? You haven’t had to dream the thing up.
Host trial characteristics, stage of trial development
and the level of service provided by the CTU were seen
as critical for determining suitability for a SWAT. The
complexities associated with running a SWAT were felt
to be reduced where CTUs provide a full trial service
(as opposed to data management only) and where they
are involved in the design and development of the trial
from an early stage. Other potential facilitators in-
cluded checklists or guidance for identifying suitable
host trials, detailing what needs to be taken into ac-
count when negotiating access for the SWAT:
In X CTU you buy the whole service. They are very,
very reluctant to take on a trial if they are not running
it completely, so there is the potential to bolt stuff on.
…in Y CTU there is a much wider range of support
…[they] would run things completely but also there
were investigators who would just buy data
management … so if they’re doing trial management
themselves and you suggest doing an embedded
methodological study that will affect the working life of
their trial manager, I think you’re going to struggle …
External review as part of funding or ethics applica-
tions was seen as problematic, with a SWAT seen as
having the potential to cause confusion, detract from the
main trial or, at worst, generate objections that under-
mine the host trial or delay its implementation. Provid-
ing directions from funders to peer reviewers on how
SWATs should be assessed was seen as useful:
Funders and the referee, it’s not just funders, it’s
referees get…and they might, sort of, focus on making
hugely critical comments on an embedded trial that
they profoundly disagree with or something and that
might damage the whole…there’s a fear it might
damage the whole proposal.
Greater uncertainty was expressed about how SWATs
would be reviewed within ethics, with a general sense that
a SWAT could cause complications. This was felt par-
ticularly where SWAT methodology might diverge
from standard practice. Examples included cases
where there is no pre-notification of participants in a
SWAT or where a power calculation for a SWAT is
less appropriate.
Potential facilitators included engaging with the ethics
committees to discuss whether guidance could be given
on how this type of work should be treated:
Some [research ethics committees ] still specialise in
drugs, some will specialise in radiotherapy, some
around consent for children…why not have a few
ethics committees think about embedded methodology,
or methodology in general?
The major barriers perceived by researchers in relation
to trial process and conduct were focused on the early
phases of the research process (concept, development,
funding and review). However, a number of concerns
relating to trial implementation were also identified. Trial
setup is a time-critical period in the life of the trial.
Reservations were expressed about the practicality of
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running a SWAT if it added to the burden of setup. Vari-
ous solutions were suggested, including delaying the start
of the SWAT or using a design (such as cluster random-
isation) that simplified the recruitment work on site, al-
though there were concerns that these types of actions
could in themselves cause complications:
…it’s to do with the centre of gravity, they don’t want
the centre of gravity of the project to shift from what
they are actually really interested in. So if … you have
a substantial chunk of your money and effort is
refocused on a methodological piece of work, you are
starting to move the centre of gravity away from what
they [funders/main trial] are really interested in and
that won’t fly.
There was also concern about monitoring and imple-
mentation fidelity of the embedded trial, particularly on
large multi-site trials where the CTU or trial team might
be remote from day-to-day recruitment practice. It was
felt that this would have to be considered when selecting
host trials.
A final concern raised was over ownership of the em-
bedded trial research and data generated and the need
to establish this early in the process.
Organisational aspects of CTUs
CTU lead interviewees were asked to consider barriers
and facilitators to embedded methodology research within
their own organisations and networks. Responses were
analysed using the McKinsey 7S model and related to five
aspects: strategy, skills, structure, style and systems.
Strategy: plan or course of action leading to the allocation
of an organisation’s finite resources to reach identified
goals
The potential of SWATs to contribute to CTU strategy
was identified in a number of key areas such as increas-
ing unit capacity, staff skills and methodology work.
However, the extent to which SWATs formed part of
CTU strategy varied considerably. Examples ranged from
explicit and enacted strategy in one CTU to different
stages of consideration or implementation:
Well it’s across the board, we try and do it on every
trial…
Okay, well we’ve been thinking about it for a long time
because we’re obviously aware that other people do it,
and some people get a lot of papers out of it, and also
it’s a potential for trial managers or trial staff to get
their own papers to lead on a paper and be a first
author. So we think it’s a good thing, and also one of
our other objectives is to do more methodological work
This included in some cases testing the idea with ex-
ternal collaborators or as part of a broad strategy to ex-
pand, increase skills and capacity, and forge links with
other university departments:
So as I said with this…this was the first kind of formal
raising of it [SWATs] at this meeting [with a group of
collaborators] and basically it got very positive
feedback and I think it will get positive feedback from
the others [collaborator group meetings] as well, and I
think part of the reason for that is that we have… but
if you look on our website you will see that we are
going to build up a very strong track record of
methodology
There was also widespread recognition of how the
CTU network could be used to facilitate greater strategic
commitment to SWATs:
I mean, perhaps it should be…we should try and
persuade one or two others just to start doing this
[SWATs] and then perhaps it would then, you know,
percolate around more.
However, given the operating pressures within CTUs,
it was unclear whether such additional work would be
undertaken without further strategic drivers, primarily
around access to funding and perceived importance.
There was awareness of new initiatives such as Trial
Forge [10] and the SWAT repository (go.qub.ac.uk/
SWAT-SWAR); however, few reported engagement, and
the links between these aspects of the trials infrastruc-
ture are only just being made.
Skills: distinctive capabilities of key personnel and the
organisation as a whole
As might be expected, skill profiles across CTUs are
broadly similar, with core staff including statisticians,
methodologists and data managers. Running SWATs
was felt to be well within the existing CTU skill set, both
in terms of individual and organisational skills:
We have all the team we need really, trial managers,
data managers, the usual randomisation services,
databases, statisticians. Then we liaise with health
economists
Two aspects of CTU staffing were seen as intrinsic to
successful SWAT implementation and delivery, both fo-
cused on the role of trial managers. Developing trial man-
ager skills was largely described in terms of on-the-job
training, with SWATs recognised as offering important
opportunities for staff to experience all aspects of trial
management and improve career options both through
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skill development and lead authorship on SWAT
publications:
My main driving force is to help my trial managers to
get publication for their CVs, that’s one of the main
reasons for doing embedded trials, as well as it’s nice
to generate the evidence, but it’s also nice to get them
through promotions committees which are easier to do
if they’ve got publications on their CVs.
The second set of comments in relation to staff con-
cerned the location of trial managers. There are much
better prospects for implementing SWATs where trial
managers are based in a CTU or closely linked depart-
ment, and several CTUs insist on this as a condition of
taking on a study:
…it will always be really important for us to have an
academic co-applicant on external studies so that we
are in a position as a CTU to be able to influence the
overall shape and design of the study…
CTUs operating a more remote model (e.g. with no
co-investigator on the trial or where they provide a sin-
gle service, such as data management) saw this as a con-
siderable barrier.
Structure: who is in charge, how decisions are made,
authority relationships
CTU leads all described broadly similar decision-making
structures within their organisations, with a board or se-
nior management team assessing each clinical trial pro-
posal. However, for SWATs, decision-making power
does not necessarily sit with the CTU. This can affect
their ability to make direct decisions about implement-
ing SWATs in a particular trial where the CTU is
dependent on a receptive CI:
One of the problems when you’re just doing it purely
service, is this issue around how much control you
have, and CIs are very different. Some are very happy
to have all the input of a CTU and in some ways
actually allow the CTU to effectively lead the study.
Others it’s the opposite
It can also have an impact on broader decisions about
CTU strategy:
I know some other units … have their own cost centre
and are, like, independent organisations in the
universities, but we’re not. So we’re in a bigger
department and that has its up and downsides, I
mean, the upside is that we have access to other
specialties, other people more easily and we can
spread the risk sometimes of if we have a short fall in
work, sometimes people can be moved to projects
within the department. I suppose the downside is we
have less control of our own destiny.
Style: characterisation of how key managers behave in
order to achieve the organisation’s goals
There was strong recognition amongst interviewees of
the importance of senior management support if SWATs
are to be more widely adopted. This ranged from creat-
ing a culture of expectation that all trials will seek to
adopt SWATs, to seeking and promoting specific oppor-
tunities to work collaboratively:
If you look at XXXX [CTU]… the director of that unit
will support trial managers who are interested in
running a piece of [methodological] research to do so
and to get a publication out of it… my take on it is
that a) it’s supporting the methodological literature,
but b) it’s also supporting the individual trial manager
and it’s part of the culture. If you’re in a different unit
where [the leadership] see the trial manager’s role as
someone who essentially implements the trial, it might
be much harder.
Systems: procedures and routine processes, including how
information moves around the organisation
The nature of trials work means that CTUs have high
levels of expertise in developing and implementing sys-
tems and offer great scope for routinizing SWATs. How-
ever, the lack of SWATs means that, in practice, these
systems rarely exist. Additionally, because most SWATs
have been conducted in an ad hoc way to date, there is
little shared learning on what processes seem to work
best.
Looking at existing systems and identifying where
SWAT elements could be included was felt to be a
straightforward process for CTUs, but it was also felt to
be a minor consideration in relation to the other barriers
faced, such as funding, consensus around what to test
and resources to develop ideas and materials.
Discussion
Awareness of recruitment and retention issues and accept-
ance of the need for SWATs amongst the wider research
community remains a considerable barrier to the wider
adoption of SWATs. There is also a gap between the percep-
tions of funders and researchers about the availability of
funding. A number of simple actions could remedy this:
greater clarity from funders about the status of funding for
SWATs; actions that send clear signals to trial teams and
beyond about support for SWATs (changes to application
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forms to outline any SWATs included in the trial);
and greater willingness from CIs and methodologists
to discuss proposals for SWATs with funders prior to
submission of a bid.
Limitations
It is recognised that SWAT methodology will be more
or less relevant for certain types of trials and settings.
Whilst all interviewees here broadly supported the
SWAT approach, two interviewees also highlighted the
importance of other approaches to improving trial meth-
odology, including improving internal CTU systems or
focusing on leadership style and management of trial
teams [11, 12], that may not require testing through em-
bedded methodology research.
The sample in this research is small and to some de-
gree self-selected. In particular, the representatives of
trial funders may not reflect the views or priorities of
the funding organisations as a whole. The views
expressed here relate to the present delivery of publicly
funded trials in the UK and may suffer from limited ex-
ternal validity to other contexts where funding and CTU
arrangements may differ. Note also that priorities for
methodological research differ between settings, with re-
cruitment and retention less of an issue in low- and
middle-income countries compared to outcome assess-
ments [13].
Implications
Real concerns exist about the balance between SWATs
and host trials. Existing arguments have tended to focus
on the lack of trial methodology evidence per se and the
rationalisation therefore that SWATs are ‘a good thing’
in general. Implementation of SWATs will be aided by
the development of more sophisticated arguments that
demonstrate better awareness of the balance between
the needs of a SWAT and the host trial and make expli-
cit the synergy between a SWAT and host trial, including
known or anticipated recruitment or retention chal-
lenges in the host population and use of designs, such as
an adaptive embedded trial design, with clear indication
of how and when the host trial team will review recruit-
ment data and switch to the preferred recruitment
method identified by the SWAT.
Although trialists and CTUs are well equipped (in
terms of skills) to implement SWATs, the processes are
often poorly understood. Additionally, there are areas
where SWAT methodology diverges from standard trial
practice. Various materials exist via current initiatives,
such as the SWATs repository and Trial Forge [10, 14],
that could form the basis for a set of guidelines for run-
ning SWATs.
The CTU network offers unique opportunities to develop
a clearer strategy with regard to embedded methodology
trials. To date, efforts have been ‘piecemeal’ and opportun-
istic, but there is recognition that CTUs could develop a
clear strategy which could be achieved in a number of ways:
consensus about intervention priorities; collaboration be-
tween a number of CTUs to promote and implement inter-
ventions with a specific evidence goal in mind; or efforts
from an individual CTU to promote and implement an
intervention over a number of trials with regard to a spe-
cific recruitment process or question.
Conclusions
The need for evidenced-based approaches to trial deliv-
ery is well established amongst the interviewees in this
study. The CTU network already has the skills and ex-
pertise necessary to implement the widespread adoption
of evidence-based approaches to trial methodology.
However the approach, whilst appealing on a number of
levels, is not without challenges. If SWAT methodology
is to move beyond a fringe activity, there needs to be
considerable coordination of effort across a number of
linked activities: promoting wider understanding of the
need for evidence-based trial methodology and setting
expectations, particularly through funding policy, ethical
review guidance and other governance standards; en-
couraging formal and informal collaboration on a much
wider scale to agree on priorities for testing and setting
agendas for development of evidence in specific issues;
and formal and informal sharing of expertise and mate-
rials to support the implementation of SWATs.
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